focus -WSS

focus

author：fashion 2025-10-02 23:32:01 - browse：1

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Element Biosciences CEO lays out genome sequencing strategy

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Bird flu outbreak in cows is latest avian flu curveball

After traumatic brain injury, life support decisions can use more time

Key Senate committee drafts bipartisan bill to stem drug shortages

Make 'food is medicine' a key part of White House nutrition meeting

A new study asks: Are we harming blood donors by taking blood?

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Did the public have the right to know Arthur Ashe had AIDS?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Peter Hotez and the public health issue of online harassment

Can food be medicine? And other questions about a new push

Dobbs anniversary: the lost opportunity of abortion as health care

Grail is spending more than ever lobbying Congress

How to save PrEP access — and even expand it

Make 'food is medicine' a key part of White House nutrition meeting

focus

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Did the public have the right to know Arthur Ashe had AIDS?

Medical bills so high, Medicare adding extra digits to claim forms

Inside the fall of star MIT scientist David Sabatini

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Cholera vaccine supply gets boost as demand surges globally

focus

hotspot

focus

explore